DIVI S LABORATORIES LTD vs KILITCH DRUGS INDIA LTD
A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and KILITCH DRUGS INDIA LTD (KILITCH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs KILITCH on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
- − ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
- + ["Company has delivered good profit growth of 60.0% CAGR over last 5 years", "Company's median sales growth is 28.4% of last 10 years"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has a low return on equity of 11.4% over last 3 years.", "Company has high debtors of 186 days.", "Promoter holding has decreased over last 3 years: -4.48%", "Working capital days have increased from 71.9 days to 130 days"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.